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In mammalian cells, ~34’~” kinase undergoes phosphorylation at threonine-14, tyrosine-15 and threonine-161 in the S and Gz phases of the cell 
cycle. At the onset of mitosis, the kinase becomes dephosphorylated at threonine-14 and tyrosine-15, resulting in activation. Cdc25 phosphatase 
has been shown to dephosphorylate tyrosine-15 in vitro, but whether it also does at threonine-14 remains unclear. In this study, we have found 
that human cdc25B phosphatase dephosphorylates both threonine-14 and tyrosine-15 but not threonine-161. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
p34’d=2 kinase plays a key role in the initiation of 
mitosis [l]. The activity of this kinase is regulated by its 
phosphorylation and dephosphorylation. In yeast, 
phosphorylation occurs at the tyrosine-15 and threon- 
ine-167 residues. By contrast, in mammals, phosphoryl- 
ation takes place mainly at tyrosine-15, threonine-161 
(corresponding to threonine-167 in the yeast cdc2 ki- 
nase) and threonine-14. Phosphorylation at the threon- 
ine-161 residue is essential for the kinase activity [2], 
whereas phosphorylation at tyrosine-15 and/or threon- 
ine-14 is the major mechanism regulating this kinase 
[3,4]. The enzyme that phosphorylates tyrosine-15 is 
human ~50”” kinase [5-71, but those that phospho- 
rylate threonine- 14 and/or threonine- 16 1 are unknown. 
The ~34’~‘~ kinase is activated following dephosphoryla- 
tion by cdc25 phosphatase [&lo]. Unlike yeast, human 
cells contain three cdc25 phosphatases (A, B, C) [ll- 
131. However, the role of each remained unclear. Since 
the human ~34’~‘~ kinase is phosphorylated at tyrosine- 
15 and threonine-14, it is important to determine 
whether cdc25 phosphatases dephosphorylate not only 
tyrosine-15 but also threonine- 14, or whether an un- 
known phosphatase dephosphorylates threonine-14. 
Here, we report that human cdc25B phosphatase, the 
major species expressed at the G2lM boundary, acti- 
vates the human ~34’~‘~ kinase by dephosphorylating 
both tyrosine-15 and threonine-14. 
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2.1. Plasmid construction and expression of cdc25 protein in E. coli 
The 2.1 kb SmaI fragment of the human cdc25B cDNA was inserted 
into the BamHI site of the pET3a plasmid by blunt end ligation after 
filling the recessed 3’ termini by Klenow fragment. The plasmid was 
transfected into E. coli BL21 (pLysS) strain, and the cdc25B protein 
produced was extracted from the inclusion body according to the 
published procedure [14]. After purification by mono S column 
chromatography, the cdc25B protein was renatured as previously de- 
scribed [5]. 
2.2. Labeling of cdc2 kinase 
HeLa S3 cells were cultured in ES medium (Nissui Co., Japan) 
supplemented with 10% newborn calf serum. Logarithmically growing 
cells were synchromzed at G,/S phase by adding 1 @ml aphidicolin 
(Sigma, Co.). The synchronized cells were stored frozen until use. 
5 x lo6 cells were thawed and the cytosolic fraction was prepared as 
described previously [5]. In the presence of 1 pg human cyclin Bl, the 
cytosolic fraction was incubated for 20 min at 30°C in buffer A 
containing 50 mM Tris-HCl, pH 7.4,lO mM MgC&, 10 mM 2-mercap- 
toethanol, 1 mM EGTA and 0.1 mM [y-32P]ATP (4,000 cpm/pmol). 
After incubation, the cdc2 kinase was immunoprecipitated by anti- 
cdc2 antibody (anti-C-terminal peptide) as described previously [15]. 
To label cdc2 kinase in vivo, the logarithmically growing cells were 
washed twice with phosphate free Eagle’s MEM and incubated at 
37°C for 6 h with the medium supplemented with 10% dialyzed calf 
serum containing 3.7 MBq/ml orthophosphate. The cells were har- 
vested and washed twice with Mg2’.Ca2’-free phosphate-buffered sa- 
line (PBS-). ‘*P-Labeled cdc2 kinase was immunoprecipitated as de- 
scribed above. 
2.3. Phosphatase digestion 
The ‘*P-labeled cdc2 kinase was incubated at 37°C for 30 min in the 
presence of 1 pg human cdc25B phosphatase in 50 ~1 buffer A. After 
termination of the reaction by the addition of SDS-PAGE sample 
buffer, the product was separated on SDS12.5% PAGE. The phos- 
phatase activity of cdc25B was assayed withp-nitro-phenyl-phosphate 
(pNPP) as a substrate as reported [lo]. 
2.4. Tryptic phosphopeptide mapping and phosphoamino acid analysis 
Radioactive bands corresponding to p34”“’ kinase in SDS-poly- 
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acrylamide gel were excised, and the proteins in each band were recov- 
ered by electro-elution. The recovered proteins were digested with 
TPCK-treated trypsin (Worthington, Co.) at 37°C overnight. The 
resulting peptides were applied on thin layer cellulose plates (Merck 
5716) by electrophoresis at pH 1.9 (H,O/acetic acid/formic acid 
(88%) = 1794: 15650) in the first dimension, followed by chromatogra- 
phy in the second dimension (H,O:n-butanollpyridinelacetic 
acid = 60:75:50:15) according to the published procedures [16]. The 
separated peptides were partially hydrolyzed m constantly boiling 6 
N HCI at 110°C for 1.5 h. Phosphoamino acid analyses were per- 
formed as described previously [5]. 
3. RESULTS AND DISCUSSION 
The human cdc25B protein produced in E. coli was 
purified almost to homogeneity. It had a molecular 
weight of 68 kDa (Fig. 1A). Since 30 amino acid resi- 
dues at the amino-terminus were deleted and 14 amino 
acids derived from the vector were added to the original 
cdc25 protein in the process of insertion into the expres- 
sion vector, cdc25B expressed in E. coli was slightly 
smaller than the original protein. When detected using 
pNPP as a substrate, cdc25B had phosphatase activity, 
which was in linear proportion to the protein amount 
(Fig. 1B). Cdc25A and cdc25C, expressed in E. coli, 
have been shown to efficiently hydrolyze pNPP [lO,l 11. 
The cytosolic fraction of HeLa cells was incubated 
with human cyclin B protein. During the incubation, the 
monomeric cdc2 kinase in the cytosolic fraction was 
bound to cyclin B and subsequently phosphorylated [5]. 
When the [32P]phosphorylated cdc2 kinase was im- 
munoprecipitated and separated by SDS-PAGE, two 
‘*P-labeled bands were detectable. These bands did not 
change when incubated at 37°C for 30 min in the reac- 
tion buffer (Fig. 2A). However, treatment of the 
phosphorylated cdc2 with cdc25B protein resulted in 
disappearance of the two bands and concomitant emer- 
gence of a new radio-labeled band migrating slightly 
faster (Fig. 2B). The radioactivity in the new band (L) 
A B 
was much lower than the sum of that in the two bands 
(U and M) before treatment. Simultaneously, the cdc2 
kinase activity (Hl kinase activity) markedly increased 
(Fig. 2C). The vertebrate or mammalian ~34’~‘~ kinase 
is phosphorylated at Thr-14, Tyr-15 and Thr-161 [24]. 
The phosphopeptide map of in vivo labeled ~34’~‘~ ki- 
nase was shown in Fig. 3D. The phosphoamino acid 
analyses of these phosphopeptides showed that peptide 
1 contained both phospho-Thr and phospho-Tyr and 
that peptide 2 contained only phospho- Tyr. Peptides 3, 
4 and 5 contained only phospho-Thr (data not shown). 
These results are identical to the previous report [2]. 
Next, we investigated phosphorylation sites of each 
band by peptide mapping. The most slowly migrating 
band (U in Fig. 2A,B) mainly consisted of three phos- 
pho-peptides 1,4 and 5 (Fig. 3A). The phosphopeptides 
that were present in the middle band (M in Fig. 2A,B) 
were peptides 2, 3, 4 and 5 (Fig. 3B). Phosphopeptide 
1, which was present in the upper band, was not con- 
tained in the middle band. Phosphopeptides 2 and 3 
were faintly detected in the upper most band (U), pre- 
sumably due to contamination of the middle band (M). 
The phosphopeptides contained in the fastest migrating 
band (L in Fig. 2B) that emerged after cdc25B treatment 
were peptides 4 and 5 (Fig. 3C). The phosphorylated 
residue in peptides 4 and 5 was phospho-Thr-161. The 
peptide 1 contained both phospho-Thr-14 and 
phospho-Tyr- 15. The peptide 2 and peptide 3 contained 
only phospho-Tyr- 15 and only phospho-Thr- 14, respec- 
tively. The peptides 1, 2 and 3 that disappeared after 
cdc25 treatment contained phospho-Tyr- 15 and/or 
phospho-Thr-14. These results strongly suggest that the 
human cdc25B phosphatase dephosphorylated not only 
phospho-Tyr- 15 but also phospho-Thr-14, but not 
phospho-Thr- 161. Since the two phosphorylated bands 
(U and M) in the immunoprecipitated cdc2 kinase did 
not change at all by the incubation (Fig. 2A), the possi- 
bility was excluded that cdc25B dephosphorylated the 
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Fig. 1. Phosphatase activity of human cdc25B expressed in E. cob. Human cdc25B was produced in E. coli and purified by mono S column 
chromatography described in Materials and Methods. (A) SDS-12.5% PAGE of purified human cdc25B. The proteins were stained with Coomassie 
brilliant blue R-250. (B) The phosphatase activtty of cdc25B. The cdc25B in (A) was used as the enzyme. Phosphatase activtty was assayed with 
pNPP as the substrate. 
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Fig. 2. Dephosphorylation and activation of ~34’~” kinase by cdc25B. (A) Incubation of p34cdc* kinase without cdc25B. Lane 1, before incubation; 
Lane 2, incubation at 37°C for 30 min with buffer. (B) Dephosphorylation of p34““’ kinase by human cdc25B. Lane 1, without cdc25B (with buffer); 
lane 2, with cdc25B. (C) Hl histone kinase activity of ~34’“’ kinase with (lane 2) or without (lane 1) treatment with cdc25B. The kinase activity 
was assayed in the presence of [y-32PJATP and the radioactivity mcorported into HI htstone was detected by autoradiography. 
cdc2 kinase only at Tyr-15, and that the partially 
dephosphorylated cdc2 kinase was further dephos- 
phorylated at Thr-14 by a specific phosphatase which 
was contaminated in the cdc2 kinase preparation. 
The vertebrate or mammalian cdc2 kinase is inac- 
tivated by phosphorylation of both Thr-14 and Tyr-15 
and activated following dephosphorylation at both sites 
[3,4]. It has been shown that, in analogy to the yeast 
system, cdc25 phosphatase mediates dephosphorylation 
of phospho-Tyr-15 [g-lo], but the enzyme responsible 
Fig. 3. Phospho~ptide mapping of phospho~la~d ~34”” kinase. The phospho~ptides of three phospho~iat~ bands (U, M, L) of p34’** kinase 
in Fig. 2B were mapped on cellulose plates. The phospho~ptides were detected by imaging plate using a Fuji BAlOO. Electrophorests was run 
from left to right (anode to cathode) and chromatography was from the bottom to the top. (A) Uppermost band (U) without cdc25B. (B) Middle 
band (M) without cdc25B. (C) The fastest migrating band (L) resulting from cdc25B treatment. (D) The p34““’ kinase labeled in vivo. The peptides 
labeled x or y in (B) have not yet been characterized. 
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for the dephosphorylation of phospho-Thr-14 has re- 
mained unclear. In this report, we have shown that 
human cdc25B phosphatase, the major mitotic inducer, 
activates the ~34’~‘~ kinase by dephosphorylating both 
phospho-Tyr-15 and phospho-Thr-14. 
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